|
 |
| LETTER TO EDITOR |
|
| Year : 2012 | Volume
: 3
| Issue : 1 | Page : 40 |
|
Censoring in survival analysis: Potential for bias
Priya Ranganathan1, CS Pramesh2
1 Department of Anaesthesiology, Tata Memorial Hospital, Parel, Mumbai - 400 012, India
2 Department of Surgical Oncology, Tata Memorial Hospital, Parel, Mumbai - 400 012, India
| Date of Web Publication | 25-Jan-2012 |
Correspondence Address:
Priya Ranganathan
Department of Anaesthesiology, Tata Memorial Hospital, Parel, Mumbai - 400 012
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/2229-3485.92307
How to cite this article:
Ranganathan P, Pramesh C S. Censoring in survival analysis: Potential for bias. Perspect Clin Res 2012;3:40 |
Sir,
We read with interest the article by Singh and Mukhopadhyay [1] on survival analysis. We commend the authors for simplifying a complex topic and for their in-depth explanation of the principles of survival analysis. However, the authors have failed to adequately emphasize one of the most important assumptions of censoring - which is that the censored patients are considered to have survival prospects similar to the participants who continued to be followed. [2]
Censoring in survival analysis should be "non-informative," i.e. participants who drop out of the study should do so due to reasons unrelated to the study. Informative censoring occurs when participants are lost to follow-up due to reasons related to the study, e.g. in a study comparing disease-free survival after two treatments for cancer, the control arm may be ineffective, leading to more recurrences and patients becoming too sick to follow-up. On the other hand, patients on the intervention arm may be completely cured by an effective treatment and may no longer feel the need to follow-up. If these participants are routinely censored, the true treatment effect will not be picked up and the results of the study will be biased. Disease-free survival rates would be based on the patients who continued to be followed-up in the study, and would be overestimated for the control arm and underestimated for the treatment arm.
Several methods have been described to deal with the problem of informative censoring. These include imputation techniques for missing data, sensitivity analyses to mimic best and worst-case scenarios and use of the drop-out event as a study end-point. [3] For unbiased analysis of survival curves, it is essential that censoring due to loss to follow-up should be minimal and truly "non-informative." Failure to understand these aspects of survival analysis could lead to grossly erroneous results from perfectly well-conducted studies.
 References | |  |
| 1. | Singh R, Mukhopadhyay K. Survival analysis in clinical trials: Basics and must-know areas. Perspect Clin Res 2011;2:145-8. 
 |
| 2. | Bland JM, Altman D G. Survival probabilities (the KaplanMeier method). BMJ 1998;317:1572.
|
| 3. | Shih W. Problems in dealing with missing data and informative censoring in clinical trials. Curr Control Trials Cardiovasc Med 2002;3:4.
[PUBMED] [FULLTEXT] |
| This article has been cited by | | 1 |
The frequency of assessment of progression in randomized oncology clinical trials |
|
| Alyson Haslam, Jennifer Gill, Vinay Prasad | | Cancer Reports. 2021; | | [Pubmed] | [DOI] | | | 2 |
Do Group Memberships Online Protect Addicts in Recovery Against Relapse? |
|
| Elahe Naserianhanzaei,Miriam Koschate-Reis | | Proceedings of the ACM on Human-Computer Interaction. 2021; 5(CSCW1): 1 | | [Pubmed] | [DOI] | | | 3 |
Quantifying Withdrawal of Consent, Loss to Follow-Up, Early Drug Discontinuation, and Censoring in Oncology Trials |
|
| Brooke E. Wilson, Michelle B. Nadler, Alexandra Desnoyers, Eitan Amir | | Journal of the National Comprehensive Cancer Network. 2021; 19(12): 1433 | | [Pubmed] | [DOI] | | | 4 |
Association of an Emergency Department–embedded Critical Care Unit with Hospital Outcomes and Intensive Care Unit Use |
|
| George L. Anesi,Jayaram Chelluri,Zaffer A. Qasim,Marzana Chowdhury,Rachel Kohn,Gary E. Weissman,Brian Bayes,M. Kit Delgado,Benjamin S. Abella,Scott D. Halpern,John C. Greenwood | | Annals of the American Thoracic Society. 2020; 17(12): 1599 | | [Pubmed] | [DOI] | | | 5 |
Association of a Novel Index of Hospital Capacity Strain with Admission to Intensive Care Units |
|
| George L. Anesi,Marzana Chowdhury,Dylan S. Small,M. Kit Delgado,Rachel Kohn,Brian Bayes,Wei Wang,Erich Dress,Gabriel J. Escobar,Scott D. Halpern,Vincent X. Liu | | Annals of the American Thoracic Society. 2020; 17(11): 1440 | | [Pubmed] | [DOI] | | | 6 |
Informative censoring — a neglected cause of bias in oncology trials |
|
| Arnoud J. Templeton,Eitan Amir,Ian F. Tannock | | Nature Reviews Clinical Oncology. 2020; | | [Pubmed] | [DOI] | | | 7 |
Repeated kidney re-transplantation—the Eurotransplant experience: a retrospective multicenter outcome analysis |
|
| Volker Assfalg,Katharina Selig,Johanna Tolksdorf,Marieke Meel,Erwin Vries,Anne-Marie Ramsoebhag,Axel Rahmel,Lutz Renders,Alexander Novotny,Edouard Matevossian,Stefan Schneeberger,Alexander R. Rosenkranz,Gabriela Berlakovich,Dirk Ysebaert,Noël Knops,Dirk Kuypers,Laurent Weekers,Anja Muehlfeld,Lars-Christian Rump,Ingeborg Hauser,Przemyslaw Pisarski,Rolf Weimer,Paolo Fornara,Lutz Fischer,Volker Kliem,Urban Sester,Dirk Stippel,Wolfgang Arns,Hans-Michael Hau,Martin Nitschke,Joachim Hoyer,Stefan Thorban,Julia Weinmann-Menke,Katharina Heller,Bernhard Banas,Vedat Schwenger,Silvio Nadalin,Kai Lopau,Norbert Hüser,Uwe Heemann | | Transplant International. 2020; | | [Pubmed] | [DOI] | | | 8 |
Performance of methods to conduct mediation analysis with time-to-event outcomes |
|
| Lizbeth Burgos Ochoa,Judith J.M. Rijnhart,Brenda W. Penninx,Klaas J. Wardenaar,Jos W.R. Twisk,Martijn W. Heymans | | Statistica Neerlandica. 2019; | | [Pubmed] | [DOI] | | | 9 |
Using incidental mark-encounter data to improve survival estimation |
|
| Seth M. Harju,Scott M. Cambrin,Roy C. Averill-Murray,Melia Nafus,Kimberleigh J. Field,Linda J. Allison | | Ecology and Evolution. 2019; | | [Pubmed] | [DOI] | | | 10 |
The effect of bariatric surgery on health care costs: A synthetic control approach using Bayesian structural time series |
|
| Christoph F. Kurz,Martin Rehm,Rolf Holle,Christina Teuner,Michael Laxy,Larissa Schwarzkopf | | Health Economics. 2019; | | [Pubmed] | [DOI] | | | 11 |
Local Recurrence After Microwave Ablation of Lung Malignancies: A Systematic Review |
|
| David B. Nelson,Alda L. Tam,Kyle G. Mitchell,David C. Rice,Reza J. Mehran,Boris Sepesi,Mara B. Antonoff,Ara A. Vaporciyan,Wayne L. Hofstetter | | The Annals of Thoracic Surgery. 2018; | | [Pubmed] | [DOI] | | | 12 |
Predictors of injecting cessation among a cohort of people who inject drugs in Tijuana, Mexico |
|
| Danielle Horyniak,Steffanie A. Strathdee,Brooke S. West,Meredith Meacham,Gudelia Rangel,Tommi L. Gaines | | Drug and Alcohol Dependence. 2018; 185: 298 | | [Pubmed] | [DOI] | | | 13 |
Assessing the degree of residual confounding: a cohort study on the association between disability pension and mortality |
|
| Daniel Olsson,Kristina Alexanderson,Matteo Bottai | | European Journal of Public Health. 2018; | | [Pubmed] | [DOI] | | | 14 |
Time-varying effects of prognostic factors associated with long-term survival in breast cancer |
|
| Minlu Zhang,Peng Peng,Kai Gu,Hui Cai,Guoyou Qin,Xiao Ou Shu,Pingping Bao | | Endocrine-Related Cancer. 2018; 25(5): 509 | | [Pubmed] | [DOI] | | | 15 |
Using a Counting Process Method to Impute Censored Follow-Up Time Data |
|
| Jimmy Efird,Charulata Jindal | | International Journal of Environmental Research and Public Health. 2018; 15(4): 690 | | [Pubmed] | [DOI] | | | 16 |
Prognostic value of routine laboratory variables in prediction of breast cancer recurrence |
|
| Zhu Zhu,Ling Li,Zhong Ye,Tong Fu,Ye Du,Aiping Shi,Di Wu,Ke Li,Yifan Zhu,Chun Wang,Zhimin Fan | | Scientific Reports. 2017; 7(1) | | [Pubmed] | [DOI] | | | 17 |
Differential losses to follow-up that are outcome-dependent can vitiate a clinical trial: Simulation results |
|
| Richard F. Potthoff | | Journal of Biopharmaceutical Statistics. 2017; | | [Pubmed] | [DOI] | | | 18 |
Fifth Ovarian Cancer Consensus Conference of the Gynecologic Cancer InterGroup: first-line interventions |
|
| A. Karam,J. A. Ledermann,J.-W. Kim,J. Sehouli,K. Lu,C. Gourley,N. Katsumata,R. A. Burger,B.-H. Nam,M. Bacon,C. Ng,J. Pfisterer,R. L. M. Bekkers,A. Casado Herráez,A. Redondo,H. Fujiwara,N. Gleeson,O. Rosengarten,G. Scambia,J. Zhu,A. Okamoto,G. Stuart,K. Ochiai | | Annals of Oncology. 2017; 28(4): 711 | | [Pubmed] | [DOI] | | | 19 |
The value of Chinese patents: An empirical investigation of citation lags |
|
| Christian Fisch,Philipp Sandner,Lukas Regner | | China Economic Review. 2017; 45: 22 | | [Pubmed] | [DOI] | | | 20 |
Adherence to Antiretroviral Therapy During and After Pregnancy: Cohort Study on Women Receiving Care in Malawiæs Option B+ Program |
|
| Andreas D. Haas,Malango T. Msukwa,Matthias Egger,Lyson Tenthani,Hannock Tweya,Andreas Jahn,Oliver J. Gadabu,Kali Tal,Luisa Salazar-Vizcaya,Janne Estill,Adrian Spoerri,Nozgechi Phiri,Frank Chimbwandira,Joep J. van Oosterhout,Olivia Keiser | | Clinical Infectious Diseases. 2016; : ciw500 | | [Pubmed] | [DOI] | | | 21 |
Short-term cessation of sex work and injection drug use: Evidence from a recurrent event survival analysis |
|
| Tommi L. Gaines,Lianne A. Urada,Gustavo Martinez,Shira M. Goldenberg,Gudelia Rangel,Elizabeth Reed,Thomas L. Patterson,Steffanie A. Strathdee | | Addictive Behaviors. 2015; 45: 63 | | [Pubmed] | [DOI] | | | 22 |
A new comparison of nested case–control and case–cohort designs and methods |
|
| Ryung S. Kim | | European Journal of Epidemiology. 2014; | | [Pubmed] | [DOI] | | | 23 |
Simulation studies on the estimation of total area under the curve in the presence of right-tailed censoring |
|
| Peter L. Bonate | | Journal of Pharmacokinetics and Pharmacodynamics. 2014; | | [Pubmed] | [DOI] | | | 24 |
Comparison of Success Rates Using Video Laryngoscopy Versus Direct Laryngoscopy by Residents During a Simulated Pediatric Emergency |
|
| Michael J. Sylvia,Louise Maranda,Kathryn L. Harris,Jennifer Thompson,Barbara M. Walsh | | Simulation in Healthcare: The Journal of the Society for Simulation in Healthcare. 2013; 8(3): 155 | | [Pubmed] | [DOI] | |
|
 |
|
|
|
